复发性-话题@MedSci

#复发性#

452篇内容 | 2499人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909736, encodeId=f0e81909e369b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Gastroenterology：超范围夹子在治疗复发性消化道溃疡出血中疗效要好于内镜治疗, objectType=article, longId=148849, objectId=0c41148849d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c41148849d9, replyNumber=0, likeNumber=110, createdTime=2018-10-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c41148849d9, moduleTitle=Gastroenterology：超范围夹子在治疗复发性消化道溃疡出血中疗效要好于内镜治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c41148849d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909680, encodeId=cc7b19096803a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA：口服粪便微生物胶囊治疗复发性难辨梭菌感染的疗效不次于结肠镜给药, objectType=article, longId=122471, objectId=8f3b1224e179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f3b1224e179, replyNumber=0, likeNumber=70, createdTime=2018-03-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f3b1224e179, moduleTitle=JAMA：口服粪便微生物胶囊治疗复发性难辨梭菌感染的疗效不次于结肠镜给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f3b1224e179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909715, encodeId=656c1909e15c6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Radiology：晚期复发性肝癌，拿你如何是好？, objectType=article, longId=138979, objectId=04361389e97c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04361389e97c, replyNumber=0, likeNumber=61, createdTime=2018-08-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04361389e97c, moduleTitle=Radiology：晚期复发性肝癌，拿你如何是好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04361389e97c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909693, encodeId=fac2190969333, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=ANN ONCOL：Pembrolizumab治疗复发性生殖细胞肿瘤, objectType=article, longId=128002, objectId=cc5312800282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc5312800282, replyNumber=0, likeNumber=74, createdTime=2018-05-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc5312800282, moduleTitle=ANN ONCOL：Pembrolizumab治疗复发性生殖细胞肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc5312800282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909690, encodeId=8e0e1909690fd, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, objectType=article, longId=127049, objectId=a3f612e04938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3f612e04938, replyNumber=0, likeNumber=56, createdTime=2018-12-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3f612e04938, moduleTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3f612e04938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909699, encodeId=4f88190969915, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, objectType=article, longId=128600, objectId=c14a1286000a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14a1286000a, replyNumber=0, likeNumber=64, createdTime=2018-10-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14a1286000a, moduleTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14a1286000a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909701, encodeId=85551909e01c4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？, objectType=article, longId=130439, objectId=5dcb130439ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dcb130439ce, replyNumber=0, likeNumber=64, createdTime=2018-12-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dcb130439ce, moduleTitle=J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dcb130439ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909725, encodeId=979c1909e25cf, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Stroke：急性缺血性卒中和复发性血管事件后24小时收缩压变化轨迹有何意义？, objectType=article, longId=144557, objectId=a00014455e75, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a00014455e75, replyNumber=0, likeNumber=58, createdTime=2018-09-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a00014455e75, moduleTitle=Stroke：急性缺血性卒中和复发性血管事件后24小时收缩压变化轨迹有何意义？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a00014455e75)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909712, encodeId=43db1909e1259, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：复发性多软骨炎-病例报道, objectType=article, longId=137127, objectId=7b7d13e127f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7d13e127f0, replyNumber=0, likeNumber=88, createdTime=2018-06-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7d13e127f0, moduleTitle=NEJM：复发性多软骨炎-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b7d13e127f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909683, encodeId=6b241909683de, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。, objectType=article, longId=123306, objectId=4e3712330674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e3712330674, replyNumber=0, likeNumber=70, createdTime=2018-06-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e3712330674, moduleTitle=Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e3712330674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909677, encodeId=a57c19096e73c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, objectType=article, longId=120438, objectId=26471204387a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26471204387a, replyNumber=0, likeNumber=52, createdTime=2018-09-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26471204387a, moduleTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26471204387a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909700, encodeId=34e81909e00b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：复发性颈部脓肿的鳃裂窦-病例报道, objectType=article, longId=129279, objectId=2f1c1292e945, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f1c1292e945, replyNumber=0, likeNumber=62, createdTime=2018-06-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f1c1292e945, moduleTitle=NEJM：复发性颈部脓肿的鳃裂窦-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f1c1292e945)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909708, encodeId=86dd1909e08a8, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clovis公司的PARP抑制剂美国获批用于复发性卵巢癌的维持治疗, objectType=article, longId=134828, objectId=ba40134828dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba40134828dd, replyNumber=0, likeNumber=64, createdTime=2018-05-28, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba40134828dd, moduleTitle=Clovis公司的PARP抑制剂美国获批用于复发性卵巢癌的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba40134828dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909695, encodeId=c785190969511, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=白化病合并复发性视网膜脱离一例, objectType=article, longId=128039, objectId=e0c51280396f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c51280396f, replyNumber=0, likeNumber=112, createdTime=2018-11-20, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c51280396f, moduleTitle=白化病合并复发性视网膜脱离一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0c51280396f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909709, encodeId=01dd1909e0921, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性口腔溃疡，该如何用药？, objectType=article, longId=135043, objectId=beaf13504323, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=beaf13504323, replyNumber=0, likeNumber=81, createdTime=2018-10-05, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=beaf13504323, moduleTitle=复发性口腔溃疡，该如何用药？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=beaf13504323)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909681, encodeId=59f01909681b8, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JCEM：年龄对复发性甲状腺癌患者治疗及死亡率的影响！, objectType=article, longId=122793, objectId=7d8b122e9324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d8b122e9324, replyNumber=0, likeNumber=74, createdTime=2018-10-21, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d8b122e9324, moduleTitle=JCEM：年龄对复发性甲状腺癌患者治疗及死亡率的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d8b122e9324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909704, encodeId=172b1909e04ff, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：复发性/难治性霍奇金淋巴瘤的移植治疗管理, objectType=article, longId=131455, objectId=33fe131455e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33fe131455e9, replyNumber=0, likeNumber=108, createdTime=2018-07-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33fe131455e9, moduleTitle=Blood：复发性/难治性霍奇金淋巴瘤的移植治疗管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33fe131455e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909676, encodeId=d62b19096e6e6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：依鲁替尼治疗复发性或难治性滤泡性淋巴瘤的效果。, objectType=article, longId=118210, objectId=31021182100f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31021182100f, replyNumber=0, likeNumber=62, createdTime=2017-11-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31021182100f, moduleTitle=Blood：依鲁替尼治疗复发性或难治性滤泡性淋巴瘤的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31021182100f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909665, encodeId=7fab1909665e5, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：基础代谢肿瘤体积对难治性/复发性霍奇金淋巴瘤患者预后的预测意义。, objectType=article, longId=112125, objectId=0cb011212584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cb011212584, replyNumber=0, likeNumber=69, createdTime=2018-03-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cb011212584, moduleTitle=Blood：基础代谢肿瘤体积对难治性/复发性霍奇金淋巴瘤患者预后的预测意义。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cb011212584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909694, encodeId=7837190969450, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性鼻息肉术后眶内血肿紧急眶减压术1例, objectType=article, longId=128038, objectId=0e7f128038c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e7f128038c5, replyNumber=0, likeNumber=0, createdTime=2018-12-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e7f128038c5, moduleTitle=复发性鼻息肉术后眶内血肿紧急眶减压术1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e7f128038c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Gastroenterology：超范围夹子在治疗复发性消化道溃疡出血中疗效要好于内镜治疗

2018-10-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA：口服粪便微生物胶囊治疗复发性难辨梭菌感染的疗效不次于结肠镜给药

2018-03-07

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Radiology：晚期复发性肝癌，拿你如何是好？

2018-08-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

ANN ONCOL：Pembrolizumab治疗复发性生殖细胞肿瘤

2018-05-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行

2018-12-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果

2018-10-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？

2018-12-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Stroke：急性缺血性卒中和复发性血管事件后24小时收缩压变化轨迹有何意义？

2018-09-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：复发性多软骨炎-病例报道

2018-06-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet：acalabrutinib用于治疗复发性/难治性套细胞淋巴瘤的效果和安全性。

2018-06-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。

2018-09-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：复发性颈部脓肿的鳃裂窦-病例报道

2018-06-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clovis公司的PARP抑制剂美国获批用于复发性卵巢癌的维持治疗

2018-05-28

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

白化病合并复发性视网膜脱离一例

2018-11-20

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性口腔溃疡，该如何用药？

2018-10-05

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JCEM：年龄对复发性甲状腺癌患者治疗及死亡率的影响！

2018-10-21

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：复发性/难治性霍奇金淋巴瘤的移植治疗管理

2018-07-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：依鲁替尼治疗复发性或难治性滤泡性淋巴瘤的效果。

2017-11-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：基础代谢肿瘤体积对难治性/复发性霍奇金淋巴瘤患者预后的预测意义。

2018-03-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性鼻息肉术后眶内血肿紧急眶减压术1例

2018-12-31

科室
- - 订阅+
  - 更多科室
工具
服务